New Meloxicam Capsule (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer meloxicam 7.5 mg orally once daily. If symptoms do not improve, the dose may be increased to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer this drug 15 mg orally once daily. The dose may be reduced to 7.5 mg daily depending on the response to treatment. Do not administer more than 15 mg of this drug daily. Take it with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually initiated at a dose of 7.5 mg daily. ○ Patients with severe renal impairment undergoing hemodialysis must not receive more than 7.5 mg daily.

This medication should be consulted with a doctor or pharmacist before use by individuals who regularly consume more than three drinks per day due to the risk of gastrointestinal bleeding. This medication may increase the risk of cardiovascular diseases, so patients with a history of heart disease or stroke or those with risk factors should carefully observe symptoms. This medication can cause serious gastrointestinal side effects such as gastrointestinal bleeding, ulcers, and perforation, so patients with a history of gastrointestinal diseases should use it with caution. Rarely, this medication can trigger severe skin reactions and life-threatening allergic reactions; if any abnormal skin symptoms occur, intake should be stopped immediately. This medication may affect kidney function, so patients with kidney disease or those at risk of impaired kidney function should use it cautiously. It may also affect liver function, requiring caution for patients with liver disease or abnormal liver function test results. This medication can reduce fertility, so women planning a pregnancy should avoid using it, and it should not be taken by women who are pregnant or breastfeeding. Patients with certain genetic metabolic disorders should not be administered this medication, nor should it be used by individuals with a history of allergies or hypersensitivity to this drug or similar medications. Regular tests such as blood tests, liver function tests, and kidney function tests are required while taking this medication, and any abnormal symptoms should be reported to healthcare personnel immediately. This medication may interact with other drugs, so caution is required when taken with anticoagulants, diuretics, blood pressure medications, lithium, methotrexate, etc., and all medications being taken should be disclosed to healthcare personnel. CNS side effects such as drowsiness and dizziness may occur, requiring caution when driving or operating machinery. In case of overdose, serious symptoms such as vomiting, gastrointestinal bleeding, kidney failure, or heart problems may manifest, necessitating immediate hospital treatment. This medication should not be administered to children, especially adolescents under 15 years of age. It should be used cautiously at minimal doses in the elderly due to the heightened risk of side effects related to decreased kidney and liver function. This medication should be taken at the lowest effective dose for the shortest duration possible, in accordance with the therapeutic purpose.

• Gastrointestinal bleeding
• cardiovascular thrombotic events
• myocardial infarction
• stroke
• bleeding in the stomach or intestines
• ulcers
• perforations
• exfoliative dermatitis
• Stevens-Johnson syndrome
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to store it at room temperature, between 1 and 30 degrees Celsius, to maintain its efficacy.

Appearance

A hard capsule with upper and lower parts in dark green filled with yellowish powder

Package unit

30 capsules/bottle, 300 capsules/bottle